SG Americas Securities
VTYX

SG Americas Securities’s Ventyx Biosciences VTYX Stock Holding History

SG Americas Securities’s Portfolio VTYX Stock Details VTYX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-35,896
Closed -$41K – 3650
2025
Q1 		$41K Buy
35,896
+10,746
+43% +$18.5K ﹤0.01% 3285
2024
Q4 		$55K Sell
25,150
-9,520
-27% -$21.6K ﹤0.01% 2893
2024
Q3 		$76K Buy
34,670
+20,792
+150% +$47.8K ﹤0.01% 3148
2024
Q2 		$32K Buy
+13,878
New +$57.7K ﹤0.01% 2737
2024
Q1 		– Sell
-37,261
Closed -$92K – 3477
2023
Q4 		$92K Buy
37,261
+14,177
+61% +$135K ﹤0.01% 2794
2023
Q3 		$802K Buy
23,084
+3,568
+18% +$123K 0.01% 1447
2023
Q2 		$640K Buy
19,516
+15,774
+422% +$544K ﹤0.01% 1287
2023
Q1 		$125K Sell
3,742
-4,233
-53% -$165K ﹤0.01% 2770
2022
Q4 		$262K Buy
7,975
+4,192
+111% +$124K ﹤0.01% 2025
2022
Q3 		$132K Buy
+3,783
New +$83.8K ﹤0.01% 2635

Other funds holding VTYX

Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return
AAA
Affinity Asset Advisors New York $1.94B AUM 374.45% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return
VPC
Vestal Point Capital New York $3.58B AUM 189.12% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
SCM
Sio Capital Management New York $697M AUM 79.73% 1-Year Est. Return

SG Americas Securities's VTYX Position: Q2 2025 in Review

SG Americas Securities sold out of Ventyx Biosciences (VTYX) in Q2 2025, closing a stake of 35,896 shares — an estimated $41K sold.

SG Americas Securities first reported a position in VTYX in Q3 2022 and held it in 10 quarters. The position peaked at $802K in Q3 2023. 114 funds tracked by Wall St. Rank hold VTYX as of Q2 2025.

  • SG Americas Securities reported no remaining Ventyx Biosciences position as of Q2 2025 after selling out during the quarter.
  • SG Americas Securities sold 35,896 Ventyx Biosciences shares in Q2 2025, an estimated $41K.
  • SG Americas Securities first reported a position in Ventyx Biosciences in Q3 2022 and held it in 10 quarters.
  • SG Americas Securities's Ventyx Biosciences position peaked at $802K in Q3 2023.
  • 114 funds tracked by Wall St. Rank held Ventyx Biosciences as of Q2 2025.

Based on SG Americas Securities's 13F filing for Q2 2025, filed 8 Aug 2025.